Neovasc Inc. (NVCN)

Market Cap	82.45M
Revenue (ttm)	3.11M
Net Income (ttm)	-33.52M
Shares Out	2.76M
EPS (ttm)	-12.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,864
Open	29.41
Previous Close	29.42
Day's Range	29.40 - 29.89
52-Week Range	4.59 - 29.88
Beta	2.01
Analysts	Buy
Price Target	n/a
Earnings Date	May 10, 2023

About NVCN

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Fred Colen
• Employees: 49
• Stock Exchange: NASDAQ
• Ticker Symbol: NVCN

Financial Performance

In 2021, Neovasc's revenue was $2.55 million, an increase of 30.14% compared to the previous year's $1.96 million. Losses were -$24.89 million, -13.26% less than in 2020.